Holen Sie sich die Stockscreener-App
164.40
0.29%
0.4713
Handel nachbörslich:
164.40
0.0044
+0.00%
Schlusskurs vom Vortag:
$163.92
Offen:
$163.27
24-Stunden-Volumen:
11,137
Relative Volume:
0.47
Marktkapitalisierung:
$3.19B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.45%
1M Leistung:
+7.62%
6M Leistung:
-6.94%
1J Leistung:
+10.93%
1-Tages-Spanne:
$163.14
$165.25
1-Wochen-Bereich:
$158.84
$165.25
52-Wochen-Spanne:
$141.38
$183.59
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Company Profile
Firmenname
First Trust Nyse Arca Biotechnology Index Fund
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie FBT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBT
First Trust Nyse Arca Biotechnology Index Fund
|
164.40 | 3.19B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
277.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
563.51 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
566.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
220.85 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
485.93 | 124.43B | 0 | 0 | 0 | 0.00 |
First Trust Nyse Arca Biotechnology Index Fund Aktie (FBT) Neueste Nachrichten
How to Take Advantage of moves in (FBT) - news.stocktradersdaily.com
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
Eli Lilly and Co (NYSE:LLY): Promising Breakthrough in Weight-Loss Treatments - Value The Markets
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Learn to Evaluate (FBT) using the Charts - news.stocktradersdaily.com
StockWatch: Trump Tariffs Take Biopharma on a Roller Coaster Ride - Genetic Engineering and Biotechnology News
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Monday's ETF Movers: FBT, XBI - Nasdaq
Where are the Opportunities in (FBT) - news.stocktradersdaily.com
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value The Markets
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(FBT) Trading Advice - Stock Traders Daily
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
First Trust Nyse Arca Biotech Etf (FBT) - INDmoney
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds - br.ADVFN.com
(FBT) Investment Report - Stock Traders Daily
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
How To Trade (FBT) - Stock Traders Daily
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Should You Invest in the iShares Biotechnology ETF (IBB)? - TradingView
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - TradingView
(FBT) Trading Report - Stock Traders Daily
(FBT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
LifeSci Capital Initiates Coverage of Biotech Exchange Traded Funds (ETFs) - AccessWire
When the Price of (FBT) Talks, People Listen - Stock Traders Daily
XBI: 3 Biotech ETFs for Diversified Innovation Exposure - StockNews.com
This Warren Buffett-Owned ETF Threatens SPY's Dominance - Inkl
Vanguard's S&P 500 ETF Hits $100 Billion Inflows In 2024: Is SPY's Crown At Risk? - Inkl
(FBT) Long Term Investment Analysis - Stock Traders Daily
Top 5 Life Science ETFs in 2024 - Investing News Network
Hedge funds were net buyers of financials, healthcare for week: Goldman Sachs - MSN
FBT Crowded With Sellers - Nasdaq
5 Biggest Biotechnology ETFs in 2024 - Nasdaq
(FBT) Technical Data - Stock Traders Daily
Analysts Forecast 26% Upside For FBT - Nasdaq
Is Semaglutide a Band-Aid, or a Solution? - Securities.io
Best Biotech ETFs to Watch Right Now - The Motley Fool
Training The Immune System To Attack Cancer With Probiotics - Securities.io
New mRNA Vaccine Could Tackle Antibiotic Resistant C. difficile Infections - Securities.io
Coffee crowned king of commodities - New Zealand Herald
Fighting Cancer with BioTech – Why mRNA Vaccines Are Such a Leap Forward - Securities.io
Finanzdaten der First Trust Nyse Arca Biotechnology Index Fund-Aktie (FBT)
Es liegen keine Finanzdaten für First Trust Nyse Arca Biotechnology Index Fund (FBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):